WebAug 24, 2015 · Drug: regadenoson Detailed Description The investigators hypothesize that HFpEF is associated with reductions in myocardial blood flow and energy utilization and increased myocardial fibrosis as compared to age and gender matched hypertensive and healthy controls. Webregadenoson (Rx) Brand and Other Names: Lexiscan Classes: Diagnostic Imaging Agents Dosing & Uses AdultPediatric Dosage Forms & Strengths intravenous solution 0.4mg/5mL …
Regadenoson RxWiki
WebJun 7, 2024 · Regadenoson Intravenous Solution, Intravenous. Regadenoson is an A2A adenosine receptor agonist that causes coronary vasodilation and used for myocardial perfusion imagining. Manufactured by Astellas and FDA approved April 10, 2008. Regadenoson rapidly increases coronary blood flow (CBF) which is sustained for a short … WebApr 16, 2013 · Regadenoson Other Study ID Numbers IRB00062632 REGA12I11 (Other Identifier: Other) This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact [email protected]. michael harris kcoh
Regadenoson on Myocardial Ischemia and Coronary Artery …
WebDoing so will only opt you out of the Pfizer Hospital US Website Texting program; you will remain opted in to any other Pfizer Inc. text message program(s) to which you separately opted in To request more information or to obtain help, text HELP to 292-89 You can also call customer service at 1-844-646-4398 WebREGADENOSON Pfizer REGADENOSON (regadenoson) This product information is intended only for residents of the United States. for Healthcare professionals: … WebDec 10, 2024 · The recommended dose of LEXISCAN is 5 mL (0.4 mg regadenoson) administered as an intravenous injection within 10 seconds. • Patients should be instructed to avoid consumption of any products containing methylxanthines, including caffeinated coffee, tea or other caffeinated beverages, caffeine-containing drug products, … michael harris interview